SENSEX 25927.66 120.56 0.47% NIFTY 7947.40 39.15 0.50% Industry: Medical/Healthcare Company Glenmark Pharmaceuticals Ltd Glenmark Pharmaceuticals is currently trading at Rs. 896.60, up by 7.50 points or 0.84% from its ... Finalaya.com, 3 weeks ago
Glenmark Pharma receives ANDA approval for Tretinoin capsules, 10 mg - Money Control, 3 weeks ago
Glenmark Pharma gains after USFDA approval for Tretinoin capsules - Business Standard India, 3 weeks ago
3 images for "glenmark generics inc"
GLENMARK PHARMACEUTICALS : unveils strategic blueprint to transition into an innovation‐led global pharmaceutical organization, stocks up by 1.35%
The Blueprint conveys the Company's greater business alignment expanding generics to prioritizing research and development efforts in three key therapeutic areas: oncology, respiratory and dermatology. Glenmark Pharmaceuticals Ltd. (GPL) , a global ...4 Traders, 1 month ago GLENMARK PHARMACEUTICALS : to enhance R&D activity and focus on specialty products for growth 4 Traders, 1 month ago Glenmark Launches First and Only Generic Version of Zetia® in the United States Equity Bulls, 1 month ago GLENMARK GETS GROWTH SHOT WITH CHOLESTEROL DRUG LAUNCH IN US Pharmacy Choice, 1 month ago
LIDOCAINE OINTMENT USP, 5% ￼ Marketed by: Glenmark Pharmaceuticals, Inc Compare to: Xylocaine Ointment, 5% (AstraZeneca) Indication: Glenmark Pharmaceuticals, Inc, has announced final approval for its generic version of Xylocaine Ointment, 5%.Pharmacy Times, 2 weeks ago Generic Product News (November 2016) » Pharmacy Times, 2 months ago
Glenmark Pharmaceuticals has received final approval from the US Food and Drug Administration (USFDA) for selling its generic version of tretinoin capsules 10 mg. The drug is used for the treatment of leukaemia. Tretinoin capsules are the generic ...4 Traders, 3 weeks ago Glenmark pharma receives US regulator's approval for leukemia treatment drug India TV, 3 weeks ago Glenmark gets USFDA nod for leukemia treatment drug Moneycontrol.com, 3 weeks ago 12/28/16 - GLENMARK GETS FDA NOD FOR LEUKAEMIA TREATMENT DRUG Pharmacy Choice, 3 weeks ago
Glenmark Pharmaceuticals rose 0.87% to Rs 918.95 at 9:25 IST on BSE after the company announced the launch of first and only generic version of Zetia in the United States. The announcement was made after market hours yesterday, 12 December 2016. ...Capital Market, 1 month ago
D. Del. (2016) On August 31, 2016, Judge Richard G. Andrews of the District of Delaware ruled in favor of Fitzpatrick's client Sanofi,upholding the validity of U.S. Patent No. 8,410,167. The 167 patent is directed to the use of Sanofi's Multaq® ...Fitzpatrickcella.com, 2 months ago
This week, Natco Pharma received the US FDA nod for Generic Bendamustine HCL powder, while Lupin received the nod for generic Evoxac Capsules. IIFL presents a weekly snapshot of all the major happenings in the Pharmaceuticals industry. Top News ...Pharmacy Choice, 2 weeks ago 12/30/16 - Pharmaceuticals Newsletter - December 26 to 30, 2016 [India Infoline News Service] Pharmacy Choice, 3 weeks ago Glemark Pharma bags approval for Tretinoin Capsules HT Syndication, 3 weeks ago Pharmaceuticals Newsletter - December 12 to 16, 2016 [India Infoline News Service] Pharmacy Choice, 1 month ago
Jet Airways: Airline major Jet Airways on Monday said that it will introduce its wide-body Airbus A330 aircraft on certain additional domestic and international routes. Glenmark Pharmaceuticals: The company has been granted final approval by the ...India Infoline, 3 weeks ago
Mr. Tony Pera reports ENDO BEGINS SHIPMENT OF GENERIC ZETIA One of Endo International PLC's operating companies, Par Pharmaceutical, has begun shipping ezetimibe 10-milligram tablets, the generic version of Merck's Zetia. Par Pharmaceutical is ...Stockwatch, 1 month ago Endo Begins Shipment of Generic ZETIA® 4 Traders, 1 month ago Endo International Begins Shipment of Generic ZETIA BioSpace, 1 month ago
Case Name: , Civ. No. 14-878-LPS-CJB, 2016 U.S. Dist. LEXIS 94438 (D. Del. July 20, 2016) (Burke, M.J.) Drug Product and Patent(s)-in-Suit: Coreg® (carvedilol); U.S. Patent No. RE40,000 (the 000 patent) Nature of the Case and Issue(s) Presented: ...JD Supra, 2 months ago
on your WebpageAdd Widget >Get your members hooked!